Cargando…

Metformin Inhibits Mitochondrial Complex I To Promote Health

The major function of mitochondria in cellular homeostasis has been the generation of ATP through oxidative phosphorylation. However, we have previously demonstrated that mitochondria can serve as signaling organelles by releasing low levels of reactive oxygen species (ROS) and TCA cycle metabolites...

Descripción completa

Detalles Bibliográficos
Autor principal: Chandel, Navdeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680347/
http://dx.doi.org/10.1093/geroni/igab046.1760
_version_ 1784616726001876992
author Chandel, Navdeep
author_facet Chandel, Navdeep
author_sort Chandel, Navdeep
collection PubMed
description The major function of mitochondria in cellular homeostasis has been the generation of ATP through oxidative phosphorylation. However, we have previously demonstrated that mitochondria can serve as signaling organelles by releasing low levels of reactive oxygen species (ROS) and TCA cycle metabolites that are essential for hypoxic activation of HIF, antigen activation of T cells, cellular differentiation and proliferation of cancer cells. The anti-diabetic drug metformin has been proposed to inhibit mitochondrial complex I. We will present data indicating that metformin inhibits mitochondrial complex I to exert it’s biological effects through controlling ROS, ATP, and NAD+.
format Online
Article
Text
id pubmed-8680347
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86803472021-12-17 Metformin Inhibits Mitochondrial Complex I To Promote Health Chandel, Navdeep Innov Aging Abstracts The major function of mitochondria in cellular homeostasis has been the generation of ATP through oxidative phosphorylation. However, we have previously demonstrated that mitochondria can serve as signaling organelles by releasing low levels of reactive oxygen species (ROS) and TCA cycle metabolites that are essential for hypoxic activation of HIF, antigen activation of T cells, cellular differentiation and proliferation of cancer cells. The anti-diabetic drug metformin has been proposed to inhibit mitochondrial complex I. We will present data indicating that metformin inhibits mitochondrial complex I to exert it’s biological effects through controlling ROS, ATP, and NAD+. Oxford University Press 2021-12-17 /pmc/articles/PMC8680347/ http://dx.doi.org/10.1093/geroni/igab046.1760 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Chandel, Navdeep
Metformin Inhibits Mitochondrial Complex I To Promote Health
title Metformin Inhibits Mitochondrial Complex I To Promote Health
title_full Metformin Inhibits Mitochondrial Complex I To Promote Health
title_fullStr Metformin Inhibits Mitochondrial Complex I To Promote Health
title_full_unstemmed Metformin Inhibits Mitochondrial Complex I To Promote Health
title_short Metformin Inhibits Mitochondrial Complex I To Promote Health
title_sort metformin inhibits mitochondrial complex i to promote health
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680347/
http://dx.doi.org/10.1093/geroni/igab046.1760
work_keys_str_mv AT chandelnavdeep metformininhibitsmitochondrialcomplexitopromotehealth